The present invention relates generally to novel macrocycles of Formula (I): ##STR00001## or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, L, M, W, Z, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, and R.sup.10 are as defined herein. These compounds are selective inhibitors of the serine protease coagulation factor VIIa which can be used as medicaments.

 
Web www.patentalert.com

< G-type peptides to ameliorate atherosclerosis

> Substituted oxazolidinones and their use in the field of blood coagulation

> Quinoxaline derivatives as PI3 kinase inhibitors

~ 00545